WELCOME TO The data analytics REPORT
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
devclass.com | February 20, 2020
With OpenStacks Train release out for a while, Red Hat has now finished work on version 16 of OpenStack Platform, its commercial offering of the cloud computing platform.According to the IBM subsidiary, the product aims at service providers looking to run workloads from the areas of network function virtualisation, artificial intelligence and machine learning, as well as high performance and edge computing. Version 16 is based on the Train release, but comes with a couple of special features to ...
BIG DATA MANAGEMENT
Alteryx | October 22, 2021
Alteryx, Inc. , the Analytics Automation company, today announced that it has acquired Silicon Valley-based Lore IO, a no-code AI-enabled data modeling platform that rapidly deploys analytics that adapt easily within a changing business environment. The acquisition of Lore IO provides Alteryx with the talent and technical know-how to leverage cloud-native, elastic compute within Alteryx Designer Cloud and Alteryx Machine Learning, allowing customers to analyze large datasets for actionable self-...
Brinker International, Teradata | July 23, 2020
Teradata, the cloud data and analytics company, today announced that after an evaluation of other cloud analytics offerings on the market, Brinker International, Inc. has reinvested with Teradata, leveraging the Teradata Vantage platform – delivered as-a-service, on Amazon Web Services (AWS) – as the core of its data foundation to facilitate advanced analytics, machine learning and data science across the organization.
Brinker is one of the world's leading casual d...
drugtargetreview.com | February 04, 2020
Researchers have developed a novel method for producing lung cells in vitro using machine learning. The creators of the artificial intelligence technique believe their work will improve models of lung disease and laboratory testing of treatments.The collaboration between the Center for Regenerative Medicine (CReM) at Boston University and the Carnegie Mellon University (CMU), both US, highlighted that treating induced pluripotent stem cells (iPSCs) with growth factors can result in an impure col...
BUSINESS INTELLIGENCE, BIG DATA MANAGEMENT
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE